0001225208-24-001900.txt : 20240212 0001225208-24-001900.hdr.sgml : 20240212 20240212192522 ACCESSION NUMBER: 0001225208-24-001900 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240208 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taubert Jennifer L CENTRAL INDEX KEY: 0001745938 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 24622075 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0508 4 2024-02-08 0000200406 JOHNSON & JOHNSON JNJ 0001745938 Taubert Jennifer L ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 EVP, WW Chair, Pharmaceuticals 0 Common Stock 2024-02-08 4 M 0 3739.0000 0.0000 A 143329.0010 D Common Stock 2024-02-08 4 F 0 1913.0000 156.3300 D 141416.0010 D Common Stock 2024-02-09 4 M 0 59397.0000 90.4400 A 200813.0010 D Common Stock 2024-02-09 4 S 0 59397.0000 156.2700 D 141416.0010 D Restricted Share Units 2024-02-08 4 M 0 3739.0000 0.0000 D 2024-02-08 Common Stock 3739.0000 0.0000 D Employee Stock Options (Right to Buy) 90.4400 2024-02-09 4 M 0 59397.0000 0.0000 D 2017-02-11 2024-02-09 Common Stock 59397.0000 0.0000 D Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Shares withheld for payment of taxes upon vesting of Restricted Share Units. This transaction was executed in multiple trades at prices ranging from $156.180 to $156.360. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Raavi K. Deol, as attorney-in-fact for Jennifer Taubert 2024-02-12